Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
Clinical trial NCT06517732 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06517732
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-26
- Primary completion
- 2026-12-31
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.